Stock Screener App

Frei -

Installieren

1.0522

6.64% -0.0778

Tscan Therapeutics Inc (TCRX)

Überblick Nachrichten Preisverlauf Financials Forum Prognose

Finanzdaten der Tscan Therapeutics Inc-Aktie (TCRX)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	2.23% 2.567	2.511	3.076	2.171	0.665
Operating Expenses	33.21% 26.43	39.56	41.73	38.42	37.38
Interest Income/Expense	0.43% 0.702	0.699	0.689	0.679	0.784
Benefits Costs and Expenses	25.54	-	-	36.30	36.47
Costs And Expenses	35.43% 25.54	39.56	41.73	36.30	36.47
Operating Income/Loss	35.61% -23.86	-37.05	-38.65	-36.25	-36.71
Income/Loss From Continuing Operations Before Tax	1,015% -22.98	2.511	3.076	-34.13	-35.81
Income/Loss From Continuing Operations After Tax	35.66% -22.98	-35.71	-36.95	-34.13	-35.81
Net Income/Loss	35.66% -22.98	-35.71	-36.95	-34.13	-35.81
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	99.98% 0.0285	129.84	129.73	129.68	2.9545
Diluted Average Shares	99.98% 0.0285	129.84	129.73	129.68	2.9545
Basic Earnings Per Share	35.71% -0.18	-0.28	-0.28	-0.26	-0.30
Diluted Earnings Per Share	35.71% -0.18	-0.28	-0.28	-0.26	-0.30
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

RPRX

$45.87

0.18%

ROIV

$28.99

1.33%

MRNA

$54.07

1.61%

BNTX

$90.20

0.16%

INSM

$139.44

0.28%

ONC

$288.30

0.99%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters